Breast Cancer Survivors' Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence

被引:12
作者
Ibrar, Maryam [1 ]
Peddie, Nicola [1 ]
Agnew, Sommer [1 ]
Diserholt, Amanda [2 ]
Fleming, Leanne [1 ]
机构
[1] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Scotland
[2] Canterbury Christ Church Univ, Sch Psychol & Life Sci, Canterbury, England
来源
FRONTIERS IN PSYCHOLOGY | 2022年 / 13卷
关键词
breast cancer; hormone therapy; lived experience; side effects; adherence; COGNITIVE-BEHAVIOR THERAPY; ENDOCRINE THERAPY; INSOMNIA; WOMEN; PERSISTENCE; DEPRESSION; RECURRENCE; TAMOXIFEN; SYMPTOMS; EFFICACY;
D O I
10.3389/fpsyg.2022.861198
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
ObjectivesSide effects from Hormone Therapy (HT) impact medication adherence in breast cancer survivors. Understanding the most distressing HT side effects and their impacts may inform the development and implementation of interventions to alleviate these side effects and maximise HT adherence. This study aimed to explore the lived experience of adjuvant HT and understand the impact of HT side effects on adherence in a sample of breast cancer survivors. MethodsTwenty-five female breast cancer survivors who were currently taking adjuvant HT participated in the study. One-to-one, online, semi-structured interviews were conducted to explore (i) specific side effects from HT and (ii) the impact of these side effects on HT adherence. Data were analysed using Thematic Analysis. ResultsThe most commonly reported side effects were sleep disturbance, hot flashes, anxiety, and joint pain. Data exploring the impacts of these side effects on HT adherence were thematically synthesised into four analytical themes: "A bitter pill to swallow," "Seeking relief," "Taking control," and "The only way out is through." These themes encompass 14 sub-themes that encapsulate participants' daily struggle with HT side effects and the coping strategies developed to manage these. ConclusionAdverse side effects from HT, such as sleep disturbance, hot flashes, pain and anxiety, impair quality of life and increase the likelihood of participants' becoming non-adherent to HT medication. In order to maximise HT adherence and reduce breast cancer mortality, HT side effects should be closely monitored to identify individuals who would benefit from targetted intervention strategies aimed at alleviating these side effects.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Hobson's choice or a horned dilemma: a grounded theory on adherence to adjuvant endocrine therapy verified with breast cancer survivors
    AlOmeir, Othman
    Patel, Nilesh
    Donyai, Parastou
    SUPPORTIVE CARE IN CANCER, 2022, 30 (12) : 10127 - 10136
  • [42] Adherence to adjuvant endocrine therapy after breast cancer in Sweden - a nationwide cohort study in 1-, 3-and 5-year survivors with a focus on regional differences
    de Jong, Anna
    Von Wachenfeldt, Anna
    Nystrom, Lennarth
    Andersson, Anne
    ACTA ONCOLOGICA, 2024, 63 : 901 - 908
  • [43] The maintenance effect of acupuncture on the side effects of breast cancer endocrine therapy A protocol for systematic review and meta analysis
    Shi, Kejin
    Tang, Ying
    He, Fengyi
    Xiao, Xiao
    Zhang, Jiayuan
    Jin, Yuxia
    Wang, Yunxia
    Zhang, Qi
    MEDICINE, 2020, 99 (24) : E20567
  • [44] Factors influencing the process of medication (non-)adherence and (non-)persistence in breast cancer patients with adjuvant antihormonal therapy: a qualitative study
    Verbrugghe, M.
    Verhaeghe, S.
    Decoene, E.
    de Baere, S.
    Vandendorpe, B.
    van Hecke, A.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (02)
  • [45] Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence
    Lee, Catherine
    Check, Devon K.
    Manace Brenman, Leslie
    Kushi, Lawrence H.
    Epstein, Mara M.
    Neslund-Dudas, Christine
    Pawloski, Pamala A.
    Achacoso, Ninah
    Laurent, Cecile
    Fehrenbacher, Louis
    Habel, Laurel A.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (01) : 219 - 226
  • [46] Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
    Camacho, Fabian T.
    Tan, Xi
    Alcala, Hector E.
    Shah, Surbhi
    Anderson, Roger T.
    Balkrishnan, Rajesh
    MEDICINE, 2017, 96 (24)
  • [47] Side Effects and Its Management in Adjuvant Endocrine Therapy for Breast Cancer: A Matter of Communication and Counseling
    Johnsson, Aina
    Fugl-Meyer, Kerstin
    Bordas, Pal
    ahman, Janet
    Von Wachenfeldt, Anna
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2023, 17
  • [48] Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view
    Pellegrini, Isabelle
    Sarradon-Eck, Aline
    Ben Soussan, Patrick
    Lacour, Anne-Claude
    Largillier, Remy
    Tallet, Agnes
    Tarpin, Carole
    Julian-Reynier, Claire
    PSYCHO-ONCOLOGY, 2010, 19 (05) : 472 - 479
  • [49] Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review
    Hurtado-de-Mendoza, Alejandra
    Cabling, Mark L.
    Lobo, Tania
    Dash, Chiranjeev
    Sheppard, Vanessa B.
    CLINICAL BREAST CANCER, 2016, 16 (04) : 247 - +
  • [50] The impact of tamoxifen brand switch on side effects and patient compliance in hormone receptor positive breast cancer patients
    Zeidan, B.
    Anderson, K.
    Peiris, L.
    Rainsbury, D.
    Laws, S.
    BREAST, 2016, 29 : 62 - 67